sepsis
FDA grants breakthrough device designation to Inflammatix’s TriVerity Acute Infection and Sepsis Test System
November 29, 2023Research and Development FDA, Infections and infestations, Inflammatix, TriVerity, infection, sepsis
Inflammatix has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company’s lead …
Researchers in world-first study on antibiotic use for sepsis
June 28, 2017Research and Development NHS, antibiotic, sepsis
The University of Warwick, alongside the University of Manchester, are launching a world-first study aimed at determining the length of …
AstraZeneca and BTG sepsis drug fails
August 8, 2012Research and Development, Sales and Marketing AZD977, AstraZeneca, BTG, CytoFab, sepsis
AstraZeneca’s pipeline has suffered another blow with the troubled company halting development of an investigational sepsis drug following poor Phase …
Eisai sepsis drug fails in phase III
January 26, 2011Research and Development, Sales and Marketing Eisai, eritoran, perampanel, sepsis
A new treatment for severe sepsis could be abandoned entirely after phase III results fell short. Eisai’s eritoran did not …
